当前位置: X-MOL 学术Theranostics › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway
Theranostics ( IF 12.4 ) Pub Date : 2018-03-08 , DOI: 10.7150/thno.22641
Ema Yoshioka , Vipin Shankar Chelakkot , Maria Licursi , Suzette G Rutihinda , Jayoti Som , Leena Derwish , Justin J King , Theerawat Pongnopparat , Karen Mearow , Mani Larijani , Ann M Dorward , Kensuke Hirasawa

Protoporphyrin IX (PpIX) is an endogenous fluorescent molecule that selectively accumulates in cancer cells treated with the heme precursor 5-aminolevulinic acid (5-ALA). This cancer-specific accumulation of PpIX is used to distinguish tumor from normal tissues in fluorescence-guided surgery (FGS) and to destroy cancer cells by photodynamic therapy (PDT). In this study, we demonstrate that oncogenic Ras/mitogen-activated protein kinase kinase (MEK) pathway can modulate PpIX accumulation in cancer cells.

中文翻译:

通过靶向致癌Ras / MEK途径增强癌症特异性原卟啉IX荧光。

原卟啉IX(PpIX)是一种内源性荧光分子,可选择性地蓄积在用血红素前体5-氨基乙酰丙酸(5-ALA)处理的癌细胞中。PpIX的这种癌症特异性积累在荧光引导手术(FGS)中用于区分肿瘤与正常组织,并通过光动力疗法(PDT)破坏癌细胞。在这项研究中,我们证明了致癌性Ras /丝裂原激活的蛋白激酶激酶(MEK)途径可以调节癌细胞中PpIX的积累。
更新日期:2018-08-01
down
wechat
bug